80% of Wegovy pill users were new to weight loss drugs

Novo Nordisk reports 80% of Wegovy pill users had never taken a weight loss drug before. The pill generated $355 million in Q1 sales. It is gaining share from patients who previously used competing products. The company raised its 2026 guidance citing limited traction for Eli Lilly's Foundayo. The data suggests Wegovy is expanding the total addressable market.